EMA re-examines metoclopramide decision

23 September 2013 - Deborah Wilkes

Archived

The European Medicines Agency (EMA) is re-examining its recent recommendation on metoclopramide-containing medicines following a request from a marketing authorisation holder.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: